The FINANCIAL -- Data presented on June 7 at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that...
The FINANCIAL -- H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) on June 8 jointly announced headline results from the...
The FINANCIAL -- Amgen Inc. (Nasdaq: AMGN) on June 7 released the results of a new study comparing Nplate(R) (romiplostim) to the medical...
The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on June 8 that Jean-Philippe Santoni is appointed Senior Vice President, Industrial...
The FINANCIAL -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY), and Alkermes, Inc. (Nasdaq: ALKS) on June...
The FINANCIAL -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) on June 7 announced interim results from...
The FINANCIAL -- New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans...
The FINANCIAL -- Increasing efficiency and flexibility, reducing raw material costs: the factory of the future is more effective, more...
The FINANCIAL -- New data show that Afinitor (everolimus) Tablets significantly shrunk tumors in 33% of patients with relapsed non-Hodgkin's...
The FINANCIAL -- Cephalon, Inc. (Nasdaq: CEPH) on June 1 announced that NUVIGIL(R) (armodafinil) Tablets , a longer-lasting formulation of modafinil, is...
The FINANCIAL -- Biogen Idec (NASDAQ: BIIB) on May 30 announced data results from the CHAMPIONS (Controlled High-Risk AVONEX (interferon...
The FINANCIAL -- Exelixis, Inc. (Nasdaq:EXEL) and Bristol-Myers Squibb Company (NYSE:BMY) on May 31 reported encouraging data from an ongoing phase 2...
The FINANCIAL -- Bristol-Myers Squibb Company (NYSE: BMY) and Medarex, Inc. (NASDAQ: MEDX) on May 31 announced updated survival results from follow-up...
The FINANCIAL -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), has donated $100,000 to The American Society of Clinical Oncology...
The FINANCIAL -- Data from the Phase III ZODIAC1 study in advanced non-small cell lung cancer patients, with the investigational...